High dose hepatitis B vaccine is not effective in patients using immunomodulatory drugs: a pilot study
In patients undergoing immunotherapy, the quality of the immune response is reduced, which may negatively affect the efficacy of vaccination. This study was conducted in order to evaluate the efficacy of the hepatitis B virus (HBV) vaccine in patients using immunomodulators. Seronegative patients fo...
Saved in:
Main Authors: | Asli Haykir Solay (Author), Fatma Eser (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2019-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Three Years Surveillance Results of Catheterassociated Urinary Infections in Intensive Care Units
by: Merve Sefa Sayar, et al.
Published: (2022) -
Assessing the Immunomodulatory Effect of Size on the Uptake and Immunogenicity of Influenza- and Hepatitis B Subunit Vaccines In Vitro
by: Rick Heida, et al.
Published: (2022) -
Effect of the interval between birth and second dose of hepatitis B vaccine on perinatal transmission of hepatitis B virus
by: Tae Un Yang, et al.
Published: (2023) -
Improving birth dose coverage of hepatitis B vaccine
by: Hipgrave David B, et al.
Published: (2006) -
Immunogenicity and safety of high-dose hepatitis B vaccine among drug users: A randomized, open-labeled, blank-controlled trial
by: Yongliang Feng, et al.
Published: (2017)